GFAP and Hepatic fibrosis: Although the significance of the increase in cit-GFAP in hepatic fibrosis remains unclear, it was reported that treatment with a PAD inhibitor decreased hepatic fibrosis in an animal experimental model [28], and therefore, the citrullination of GFAP may be associated with the progression of hepatic fibrosis.